Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Forte Biosciences, Inc. (FBRX) had Return on Equity of -67.60% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-35.48M |
|
-- |
|
-- |
|
$36.60M |
|
$-36.60M |
|
$1.12M |
|
$-35.48M |
|
$-35.48M |
|
$-35.48M |
|
$-35.48M |
|
$-35.48M |
|
$-35.48M |
|
$-36.60M |
|
$-36.56M |
|
2.92M |
|
2.92M |
|
$-12.17 |
|
$-12.17 |
|
| Balance Sheet Financials | |
$61.35M |
|
$0.08M |
|
$0.21M |
|
$61.56M |
|
$9.08M |
|
-- |
|
-- |
|
$9.08M |
|
$52.48M |
|
$52.48M |
|
$52.48M |
|
6.39M |
|
| Cash Flow Statement Financials | |
$-30.75M |
|
$-35.99M |
|
$51.86M |
|
$37.12M |
|
$22.24M |
|
$-14.88M |
|
$3.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-67.60% |
-67.60% |
|
-57.63% |
|
-67.60% |
|
$8.21 |
|
$-10.56 |
|
$-10.54 |
|